Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OBIO · against 1,372 other Healthcare companies
Ranked #240 of 1,373 · scores higher than 83% of peers · safety percentile 83
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including OBIO · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | OBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 2.41× | 0.24× | 5% | 33% | |
| BetaLower is better · 1,320 reported | 0.52 | 0.53 | 51% | 33% | |
| Current ratioHigher is better · 1,338 reported | 8.26× | 2.62× | 84% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 236 | 3.5B CNY (≈$486M) | 83 | 61 | |
| 237 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 13.2B JPY (≈$90M) |
| 83 |
| 64 |
| 238 | 21.6B CNY (≈$3.0B) | 83 | 70 |
| 239 | 3.1B CNY (≈$437M) | 83 | 54 |
| 240 | 334M USD | 83 | 49 |
| 241 | 25.8B USD | 83 | 75 |
| 242 | 49.0B CNY (≈$6.9B) | 82 | 60 |
| 243 | 2.0B CNY (≈$278M) | 82 | 46 |
| 244 | 178.5B KRW (≈$129M) | 82 | 76 |